| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Calidi Biotherapeutics, Inc. (CLDI) has 8 insiders with recent SEC Form 4 filings, including 4 buys and 3 sells. CLDI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 137.1K | $28.0K | - | |
| Dir | 137.1K | $28.0K | - | |
| Dir | 125.0K | $25.5K | - | |
| Dir | 77.0K | $15.7K | - | |
| Dir | 75.0K | $15.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Camaisa Allan | Director | Sell | 850 | $1.46 | $1,236.75 | -1.1% | -77.4% | - | |
| Aug 21, 2025 | Poma Eric E | Chief Executive Officer | Buy | 25,000 | $2.00 | $50,000.00 | New | -15.3% | - | |
| Aug 21, 2025 | Leftwich Scott | Director | Buy | 125,000 | $2.00 | $250,000.00 | +2,212% | -15.3% | - | |
| Aug 21, 2025 | Jackson Andrew C. | Chief Financial Officer | Buy | 2,500 | $2.00 | $5,000.00 | New | -15.3% | - | |
| Aug 21, 2025 | Schoeneck James A47 | Director | Buy | 75,000 | $2.00 | $150,000.00 | +6,614% | -15.3% | - | |
| Dec 17, 2024 | Camaisa Allan | CEO And Chairman Of The Board | Sell | 10,000 | $1.62 | $16,200.00 | -13.0% | -49.8% | -94.0% | |
| Oct 19, 2022 | Polar Asset Management Partners Inc.72 | 10% Owner | Sell | 36,200 | $9.90 | $358,380.00 | -8.1% | +3.1% | -71.7% |